Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
2002 4
2003 3
2004 3
2005 6
2006 2
2007 1
2008 1
2009 3
2010 3
2011 5
2012 2
2013 5
2014 5
2015 1
2016 5
2017 4
2019 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Quality and Safety Education for Nurses.
Cronenwett L, Sherwood G, Barnsteiner J, Disch J, Johnson J, Mitchell P, Sullivan DT, Warren J. Cronenwett L, et al. Among authors: johnson j. Nurs Outlook. 2007 May-Jun;55(3):122-31. doi: 10.1016/j.outlook.2007.02.006. Nurs Outlook. 2007. PMID: 17524799
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. CRASH-2 collaborators, et al. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X. Lancet. 2011. PMID: 21439633 Clinical Trial.
Quantifying traffic exposure.
Pratt GC, Parson K, Shinoda N, Lindgren P, Dunlap S, Yawn B, Wollan P, Johnson J. Pratt GC, et al. Among authors: johnson j. J Expo Sci Environ Epidemiol. 2014 May-Jun;24(3):290-6. doi: 10.1038/jes.2013.51. Epub 2013 Sep 18. J Expo Sci Environ Epidemiol. 2014. PMID: 24045427
Response to Meleis's article.
Carter M, Hathaway D, Johnson J, Mundinger M. Carter M, et al. Among authors: johnson j. Nurs Outlook. 2016 Sep-Oct;64(5):408. doi: 10.1016/j.outlook.2016.06.003. Epub 2016 Jun 23. Nurs Outlook. 2016. PMID: 27445087 No abstract available.
55 results